Ferreira Jason, Akerman Paul
Division of Gastroenterology, Department of Medicine, Rhode Island Hospital, Providence, Rhode Island.
Clin Colon Rectal Surg. 2015 Sep;28(3):146-51. doi: 10.1055/s-0035-1555006.
First performed in the stomach for removal of localized gastric tumors, endoscopic submucosal dissection (ESD) has evolved into a technique that is increasingly being employed to resect colorectal lesions. As opposed to endoscopic mucosal resection (EMR), ESD allows the endoscopist to remove large specimens en bloc to provide accurate pathologic evaluation and lower local recurrence rates. ESD is an ideal technique for resection of lesions without lymph node metastases and is becoming the standard of care in Japan as outcomes data has proven it to be equally efficacious, less invasive, and inexpensive as compared with surgery; however, potential risk for complications is high and the procedure is currently not widely available in the Western world. As more interest, endoscopist training, and data supporting the technique's use mount, ESD will also likely become the standard of care in the Western world for resection of localized colorectal lesions.
内镜黏膜下剥离术(ESD)最初用于胃部局部性胃肿瘤的切除,如今已发展成为一种越来越多地用于切除结直肠病变的技术。与内镜黏膜切除术(EMR)不同,ESD使内镜医师能够完整切除大标本,以提供准确的病理评估并降低局部复发率。ESD是切除无淋巴结转移病变的理想技术,在日本正成为标准治疗方法,因为结果数据已证明与手术相比,它同样有效、侵入性更小且成本更低;然而,并发症的潜在风险很高,并且该手术目前在西方世界尚未广泛应用。随着对该技术的兴趣增加、内镜医师培训增多以及支持其使用的数据不断积累,ESD也可能会成为西方世界切除局限性结直肠病变的标准治疗方法。